ArticleCancer gene therapy2025

FBXO22 promotes HCC angiogenesis and metastasis via RPS5/AKT/HIF-1α/VEGF-A signaling axis.

Zhen Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.